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Deca-bromo-diphenyl ether (DBDE) is one of the most efficient brominated flame retardant
(BFR) available on the market. We recently demonstrated that when administered to female rat
by oral route, DBDE is efficiently absorbed, with the highest residual concentrations found in
two endocrine glands, namely the adrenal glands and the ovaries. Time-of-flight secondary ion
mass spectrometry (TOF-SIMS) imaging, a technique usually used for the study of endogenous
compounds, was applied for the first time to a persistent organic pollutant, allowing to detect
and to precisely localize DBDE residues in these two target tissues. The detection of the
bromide ion (81Br isotope) by TOF-SIMS mass spectrometry imaging allowed us to demon-
strate a marked cortical tropism of DBDE residues for the adrenal glands in female rats dosed
per os 2 mg · kg1 DBDE, daily, over 96 h. In ovaries, DBDE residues were found to be
concentrated in spots corresponding to part of the corpora lutea. Hepatic residues of DBDE
were found to be homogeneously distributed. Due to the intrinsic toxicity of DBDE, its
accumulation in the adrenal glands and the ovaries may be connected to the mechanisms of
actions by which DBDE could trigger endocrine disruption in mammals. (J Am Soc Mass
Spectrom 2010, 21, 1836–1845) © 2010 American Society for Mass SpectrometryPolybromo diphenyl ethers (PBDE) are a majorclass of brominated flame retardants (BFR). Theyare widely used to manufacture various indus-
trial and domestic devices, with the aim to prevent or
minimize fire damage. PBDE have been demonstrated
to be present in the environment [1, 2], in animals [3, 4],
as well as in human tissues [5, 6]. Among the three
different formulations of PBDEs that are currently man-
ufactured (“penta”, “octa”, and “deca”), the “deca-mix”
is the most widely used, and is nowadays in many
countries the only mix that remains marketed [7].
Deca-BDE (DBDE) is the major constituent (ca. 97%) of
the “deca” commercial mix. Lower molecular weight
PBDE (tetra-BDE to hepta-BDE) are the compounds that
have been the most extensively studied. It has been
demonstrated that some of them can induce neurotoxic
effects in mice [8, 9]. They are suspected to impact
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doi:10.1016/j.jasms.2010.06.019thyroid hormonal regulation [10], and display agonist
and antagonist activities towards the Ah receptor [11].
They also induce the expression of CYP1A1 and
CYP1A2 [12], which are proteins that belong to the
cytochrome P450 superfamily and are involved in the
metabolism of exogenous as well as endogenous mole-
cules such as steroids. DBDE was considered by man-
ufacturers to be poorly bioavailable (below 1%) due to
its high molecular weight [13], and only a limited
number of studies have examined its toxicity.
Because of technical difficulties, higher brominated
PBDEs are seldom monitored in studies dealing with
human exposure. However, when they are, DBDE and
other high molecular weight PBDE are major contami-
nants [14]. For instance, in humans, the presence of
DBDE has been reported in mother’s milk [15], serum
[16, 17] and adipose tissue [14, 18, 19]. These conclu-
sions are also supported by recent data obtained in rat
using radio-labeled [14C]-DBDE [20, 21], which demon-
strate that DBDE bioavailability is above 20%. Its resi-
dues have been shown to markedly concentrate in the
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ovaries [21]. Of particular interest is the fact that DBDE
respective residual concentrations are even higher in
these two endocrine glands than in the liver itself. In
rats dosed 2 mg · kg1 labeled DBDE, residual levels
were 11.2, 16.1 and 33.0 ppm in the liver, the ovaries,
and the adrenal glands, respectively. Moreover, part of
the detected radioactivity (about 10% in adrenal glands
and ovaries) was found to be associated with debromi-
nated metabolites. This debromination may result in the
bioactivation of PBDE, the structure of which is rela-
tively close to that of poly-chlorinated biphenyls (PCBs)
and dioxins. PBDE metabolites such as hydroxylated
tetra-BDE have been shown to be endocrine disrupting
chemicals (EDCs) [22, 23]. Thus, the consequences of the
presence of these residues in endocrine glands needs to
be better understood, beginning with the study of their
precise localization. We consequently decided to use
mass spectrometry imaging (MSI), namely time-of-
flight secondary ion mass spectrometry (TOF-SIMS)
imaging, to localize DBDE residues in the liver as well
as in the two main target tissues of DBDE in female rats:
the adrenal glands and the ovaries.
MALDI-TOF [24] and nano-SIMS [25] are two mass
spectrometry methods that are frequently used for
imaging. MALDI-TOF mass spectrometry imaging is
able to detect numerous classes of molecules (lipids,
metabolites, peptides, proteins . . .) with the possibility
to perform in situ tandem mass spectrometry experi-
ments, but with a spatial resolution limited to 50 m.
This would not allow localizing the compounds with
enough precision. Nano-SIMS imaging can detect ele-
ments with a spatial resolution of a few tens of nano-
meters. However, the field of view is only of several
tens of micrometers, which would not have enabled to
record the image of entire organs. Moreover, sample
preparation methods for nano-SIMS are relatively dif-
ficult and long to implement. Finally, taking into ac-
count the size of the tissues to be analyzed in the
present study (a few millimeters), the use of nano-SIMS
or MALDI-TOF MSI would have led to very long
acquisition times.
Until recently, the mass to charge ratio (m/z) of the
ions that could be imaged using TOF-SIMS instrument
was limited to 100–200, mainly because the ion sources
used were inefficient in transferring intact heavy mo-
lecular ions into the gas phase. The range of biological
applications was therefore relatively limited [26]. Now-
adays, thanks to the increase of sensitivity due to
advent of polyatomic ion beams such as those of gold
[27–29], bismuth [30], or C60 fullerenes [31], the field of
TOF-SIMS imaging has been greatly extended. This
method now enables drawing from various kinds of
samples the density map (image) of any ion present in
the mass spectra, with a spatial resolution from a few
m to less than 500 nm, and with a mass range which is
now reaching more than 1000 Da. In recent years, many
applications of TOF-SIMS imaging have been published
in the fields of biology and medicine [32–43]. However,it has never been directly applied to the exploration of
persistent organic pollutants such as environmental or
food contaminants.
Thus, TOF-SIMS imaging appeared to be the best
suited method to map DBDE in the liver, the adrenal
glands, and the ovaries of orally dosed rats, following the
in vivo experimental conditions already used by Riu et al.
[21], but using non-radio-labeled DBDE. Histologic stud-
ies of the imaged tissue sections were carried out in
parallel to TOF-SIMS imaging, with the aim to better
understand the tissue distribution of DBDE residues.
Experimental
Female Wistar rats, aged 12 wk (n  6), were acclima-
tized with a 12/12 h light/dark cycle for 1 wk and were
fed a standard diet with ad libitum access to water.
Three animals were force-fed, during 4 consecutive d, a
daily dose of 2 mg · kg1 DBDE (Sigma, Saint-Quentin-
Fallavier, France) dissolved in peanut oil as described
previously [21]. Three animals were forced-fed only
with peanut oil (control). Animals were euthanized by
cervical dislocation followed by exsanguinations 24 h
after the last DBDE dosage. The liver, the adrenal
glands, and ovaries were removed and immediately
frozen and stored at 80 °C until time of analysis.
Sections were made with a CM3050-S cryostat (Leica
Microsystems SA, Nanterre, France) at 20 °C for the
adrenal glands and the liver, and at 25 °C for ovaries.
Cryostat sections (10 m for adrenal glands and ovaries;
14 m for the liver) were immediately collected on a
siliconwafer (2 in. diameter polished siliconwafers; ACM,
Villiers-Saint-Frédéric, France). After each ovary section,
an adjacent section was made and collected on a glass
slide forMasson’s trichrome histologic staining (Sigma Kit
HT15; Saint-Quentin-Fallavier, France). Before analysis,
cryostat sections were dried under a pressure of a few
hectopascals for 10 min. Optical images were recorded
from both silicon wafer and glass slide sections using a
photonic BX51 microscope fitted with1.25 to50 objec-
tives (Olympus, Rungis, France) coupled to a Color View
I camera monitored by CellB software (Soft Imaging
System GmbH, Münster, Germany).
All ion images were recorded with a TOF-SIMS IV
commercial mass spectrometer (Ion-Tof GmbH, Mün-
ster, Germany) located at the Institut de Chimie des
Substances Naturelles in Gif-sur-Yvette (France). This
mass spectrometer is fitted with a bismuth liquid metal
ion gun (LMIG) delivering Bin
q bismuth cluster ions
(Bi3
 ions were selected). Primary ions reached the
sample surface with a kinetic energy of 25 keV and an
angle of incidence of 45°. The primary ion dose density
used for the experiments was set between 6  1010 and
9  1010 ions · cm2, well below the static SIMS limit
[44]. This ion dose was chosen to limit both the acqui-
sition time to 6 h and the size of the raw data files to ca.
1.5 Gb. Secondary ions were accelerated to a kinetic
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a single-stage reflectron (first-order compensation). The
effective ion flight path was 2 m. Ions were then
post-accelerated to a kinetic energy of 10 keV before
hitting a hybrid detector composed by a microchannel
plate, a scintillator, and a photomultiplier. A low-
energy electron flood gun was activated between two
primary ion pulses to neutralize the sample surface. In
this study, we used the so-called “high current bunched
mode” to set the primary ion column [45]. This mode of
operation allows reaching a spatial resolution of 2m,while
maintaining an excellent mass resolution of about M/M
8  103 (FWHM) at m/z 500, and a pulsed primary ion
current (measured with a Faraday cup located on the
grounded sample holder) of 0.35 pA for Bi3
 at 10 kHz,which
does not penalize the time required for ion images acquisi-
tion. Because of the very low initial kinetic energy distribu-
tion of the secondary ions, the relation between time-of-flight
and the square root of themass-to-charge ratiom/z is always
linear. Consequently themass spectrawere always internally
calibrated using signals from C, CH, CH2
, C2
, C3
, and
C4H
 ions, in the negative ion mode. The so-called “stage
scan” raster mode was used. In this mode, the sample is
continuously moved by the sample stage in a saw-tooth
mode and scans the whole surface area. The primary ion
beam is rastering itself inside the area of each individual
pixel. The time required to achieve one analysis with this
mode is about 6 h, mainly because of the positioning control
of the sample holder. Images were always recorded with a
number of pixels equal to 256 256, meaning that the pixel
size varied with the size of the area to be analyzed. For
example, an area of 8 8mm2would result in a pixel size of
31.25  31.25 m2.
Figure 1. TOF-SIMS negative ion mass spectr
ether at a concentration of 1 mg · mL1 in methanol/Results and Discussion
The TOF-SIMS mass spectrum, recorded in the negative
ion mode from a solution of DBDE (1 mg · mL1) is
shown in Figure 1. A very weak signal corresponding to
the molecular ion (M·, m/z 959.19 for the 79Br5
81Br5
isotopomer) was detected, showing that the detection of
this molecule based on the monitoring of the molecular
ion at the surface of a tissue section would be extremely
difficult. Besides the M· ions, several brominated iso-
topic clusters corresponding to the fragmentation of the
molecular ion via bromine atoms eliminations were
detected. These were centered on the m/z 878.10, 798.21,
and 718.29 ion peaks, respectively. The spectrum (Fig-
ure 1) also displayed the C6Br5O
 fragment ion (isoto-
pic pattern ranging from m/z 482.52, 12C6
79Br5
16O to
492.52, 12C6
81Br5
16O) generated by the cleavage of the
ether bond of the molecule. Conversely, the Br (m/z
78.91 and 80.91), Br2
 (m/z 157.82, 159.81, 161.82) and Br3

(m/z 236.71, 238.71, 240.72 and 242.71) ion peaks were by
far the most intense signals, the Br ions being the base
peak of the spectrum. The ion peaks corresponding to
the two natural isotopes of bromine, and displaying
almost the same natural abundances (50.69% and
49.31%, respectively), were the only ones detected in
organs of dosed rat. They were never detected in organs
of control rat (Figure 2). The 79Br isotope was detected
at m/z 78.906 (average of all experiments) with a devi-
ation of 13 ppm (Table 1), compared with the theoretical
mass-to-charge ratio (m/z 78.918). As shown in Figure 2,
this peak was located at the left edge of a very intense
peak corresponding to the phosphite ion PO3
 (mean
value m/z 78.961). The signal corresponding to this ion
f a standard solution of deca-bromo-diphenylum o
water 50:50 vol:vol.
r sho
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mass-to-charge ratio after each primary ion pulse, lead-
ing to a very large and distorted peak due to the dead
time of the entire electronic chain (constant fraction
discriminator and time-to-digital converter) following
the detector. This saturation is clearly evidenced in
Figure 2 (for which the intensity on the y-axis was
intentionally drawn using a log scale) by the average
chemical noise level, which is falling down just after the
intense PO3
 ion peak. The very high intensity of this ion
peak together with the close m/z ratio values of the PO3

and 79Br ions can therefore explain the large error on
the measured value of the 79Br isotope mass-to-charge
ratio. Since the PO3
 ion signal is saturated, this ion
appears as homogeneously distributed over the entire
ion image and thus makes false the representation of
the 79Br ion image. The situation was different for the
81Br isotope (theoretical mass 80.916 Da) which was
detected at m/z 80.910, with a mass deviation of 7 ppm.
This ion peak was also located at the left edge of an
intense ion peak, i.e., the bisulphite HSO3
 ion peak (m/z
80.974). Nevertheless, in this case, the HSO3
 ion peak is
Figure 2. Parts of the TOF-SIMS negative ion m
adrenal glands of control (a) and dosed rat (c), a
log scale has been chosen for the y-axis to bette
Table 1. Mass-to-charge ratio of 79Br and 81Br bromide ions m
adrenal glands of dosed rats and their deviation in ppm regardin
Theoretical m/z
Experimental m/z (measured on adrenal gland sections)
Experimental m/z (measured on ovary sections)
Experimental m/z (mean value from the two organs) 7much less intense than the PO3
 ion peak (see Figure 2).
The corresponding signal was consequently not satu-
rated, and did not disturb the ion image of the 81Br
ion, thanks to a better separation of the two peaks.
Figure S1, which can be found in the electronic version
of this article, shows that 81Br and HSO3
 ions have
different spatial distributions, while the distributions of
79Br and PO3
 ions cannot be differentiated since the
PO3
 ion signal is saturated (its ion image is uniform
and cannot exhibit any contrast).
An improved separation between these two close ion
peaks could be achieved by making the secondary ions
fly in the field-free path of the TOF-SIMS IV mass
spectrometer with a kinetic energy of 1 keV, instead of
2 keV. This was obtained by maintaining the extraction
voltage at 2 kV and by decelerating the secondary ions
only when entering the field-free path. The post-acceleration
before the detector was kept at 10 kV. Neither the
extraction of the secondary ions nor their detection
efficiency was affected. Using this method, both the
time-of-flight and the separation of all the ions were
increased by a factor of square root of two. Figure 3
spectra recorded at the surface of sections from
om ovaries of control (b) and dosed (d) rats. A
w all the peaks with very different intensities.
red by TOF-SIMS at the surface of sections from ovaries and
the exact mass
9Br Dev (ppm) 81Br Dev (ppm)
8.918 80.916
8.908 11 80.911 5
8.904 14 80.909 7ass
nd freasu
g to
7
7
7
7
8.906 13 80.909 7
1840 SEYER ET AL. J Am Soc Mass Spectrom 2010, 21, 1836–1845shows parts of the spectra obtained at the surface of an
adrenal gland section from a dosed rat, with kinetic
energies of 2 keV (top) and 1 keV (bottom), respectively.
The use of 1 keV kinetic energy led to a better mass
separation between each of the two bromide isotopes
and the PO3
 and HSO3
 ions, respectively, as indicated
in Figure 3c and d. Nevertheless the intensity of the
81Br ion peak was diminished by a factor of 2.7 when
decreasing the secondary ion kinetic energy because
this option led to a fall down in the transmission of the
time-of-flight analyzer. Regarding the separation of the
79Br and PO3
 ions, the separation’s enhancement was
not sufficient to get rid of the mix between the two ions·
Consequently, these low-energy settings of the analyzer
were not selected for the studies, and only the 81Br
isotopic ion was used for the imaging of DBDE residues
at the surface of adrenal gland and ovary sections of
dosed rats. Since the natural abundance of this isotope
accounts for nearly half of the total amount of bromine
in the samples, these difficulties in the measurements
did not affect the worthiness of the results.
Following the optimization of the method, we pro-
ceeded to the TOF-SIMS imaging of tissues of organs
from rats exposed in vivo to DBDE versus controls.
Given the technical impossibility to base on the signal
directly corresponding to DBDE, we did not aim to
distinguish between the parent compound and its me-
tabolites. However, it was previously demonstrated
that the main part of the extractible radioactivity found
in the adrenal glands and the ovaries of rats dosed
Figure 3. Parts of the TOF-SIMS negative ion m
adrenal glands of a dosed rat for 2 keV (a) and
energy.orally with DBDE in these in vivo conditions doesprimarily correspond to unchanged DBDE, while me-
tabolites (lower brominated PBDE congeners) account
only for roughly 10% of the overall residues [21].
Bromide ions were detected in hepatic parenchyma,
where they presented a homogeneous distribution,
which prevented spotting a specific localization such as
periportal or centrolobular zonation (data not shown).
Images recorded from one quarter of the surface of
adrenal gland sections of dosed and control rats are
presented in Figure 4. The left column (Figure 4a, b, and
c) shows optical images on which the red color squares
indicate the areas analyzed by TOF-SIMS imaging. The
middle column (Figure 4d, e, and f) shows the 81Br ion
images recorded from adrenal sections of dosed rats,
and the right column (Figure 4g, h, and i) shows the ion
images of the 81Br ion peak recorded from adrenal
sections of control rats. Dosed and control rats 81Br
images (d and g, e and h, f and i, respectively) in Figure
4 were generated by selecting exactly the same area. In
dosed rats, the bromide ion was clearly detected in the
cortex of the adrenal glands. The bromide ion distribu-
tion appeared heterogeneous even if it seemed that its
main localization was the outer cortex containing cells
with cytoplasmic lipid droplets enriched in aldosterone
(zona glomerulosa) and corticosterone (zona fascicu-
lata). In contrast, in control animals, no significant
amount and specific location of the bromide ion was
detected. Although the occurrence of ion suppression
effects or “matrix effects” can not be totally ruled out,
the comparison of the images obtained on the dosed
spectra recorded at the surface of sections from
and 1 keV (c) and (d) of secondary ion kineticass
(b)rats with those obtained on the control ones, and the
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species for particular zones of the organs studied. For
the latter animals, it can then be considered that the low
intensity signals recorded in the adrenal (g, h, and i
images: controls) only correspond to the HSO3
 ion
contribution at the base of the 81Br ion peak, consti-
tuting a background signal. Moreover, it is important to
notice that when the bromide ion is detected (middle
column) the amplitude mc of the color scale of each
image is greater than when not detected (right column).
The structure of PBDE is closely related to that of
PCBs, for which the toxicity was largely documented in
particular as endocrine disruptors [22, 23]. Among
Figure 4. TOF-SIMS negative ion images recor
rats. (a), (b), (c): optical images of sections from a
the areas from which the ion images (d), (e), and
(g), (h), (i): control rats, images were obtained
window as for the 81Br ion. For all ion images:
size 13.75 m2, 512 shots/pixel, fluence: 8  1
number of counts, are indicated to the right o
corresponds to the maximum number of counts m
as [0, mc]; tc is the total number of counts reco
pixels).others, it has been demonstrated that PCBs and some oftheir hydroxylated metabolites target the adrenal glands
of marine mammals, inducing the hyperplasia of the
cortical area [46]. The immunotoxicity of PCBs was
demonstrated in another study with rats, which is
consistent with the known deregulation of the immune
system by corticosteroids [47]. In the case of PCBs,
cortical hyperplasia of the adrenal glands is hypothe-
sized to be correlated with an increased production of
cortisol, which in turn triggers the down regulation of
the immune system. Given the structural similarity
between PCBs and PBDEs, it is noteworthy that DBDE
residues mainly target the outer part of the adrenal
cortex. Why these residues specifically accumulate in
t the surface of sections from adrenal glands of
al glands of dosed rats. The red squares indicate
ere recorded. (d), (e), (f): 81Br ion, dosed rats.
the selection, in the mass spectra, of the same
of view 3.52  3.52 mm2; 256  256 pixels, pixel
ns · cm2. Color scale bars, with amplitude in
h ion image. The amplitude of the color scale
icated below each ion image, and could be read
for the specified m/z (sum of counts in all theded a
dren
(f) w
after
field
010 io
f eac
c ind
rdedthis part of the adrenal glands while, in contrast, the
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understood. Though the current knowledge about the
toxicity of DBDE is insufficient to link BFR exposure to
adverse outcomes due to a disruption of the adreno-
cortical function, this hypothesis is greatly favored by
the conclusions of TOF-SIMS imaging. Further in vivo
exploration studies of the adrenal function will be
necessary to confirm this hypothesis.
Images recorded on ovary sections of dosed and
control rats are presented in Figure 5. The layout of this
figure is the same as for Figure 4. The left column shows
Figure 5. TOF-SIMS negative ion images record
(b), (c): Optical images of trichrome Masson stai
dense ovarian stroma was stained in blue wher
ovoid structures. (d), (e), (f): 81Br ion, dosed rat
selection, in the mass spectra, of the same window
6 6 to 7.4 7.4 mm2; 256 256 pixels, pixel siz
fluence: from 1.8  1010 to 4  1010 ions · cm2. C
are indicated to the right of each ion image. T
maximum number of counts mc indicated below
total number of counts recorded for the specified m/zovary micrographies recorded after Masson’s trichrome
staining (Figure 5a, b, and c). The medium column
presents the 81Br ion images recorded from ovary
sections of dosed rats (Figure 5d, e, and f) while right
column shows images from control rats. The bromide
ions appeared to accumulate in only part of the several
corpora lutea observed in the ovarian stroma from
dosed rats, while others were not colored. This result
could be explained by the fact that all corpora lutea
were not at the same stage of development. In species
like rat, which have a 4-d long estrous cycle, luteal cells
t the surface of sections from ovaries of rats. (a),
of ovaries sections of dosed rats. The collagenic
varian follicles and corpora lutea show as pink
, (h), (i): control rats, images were obtained after
or the 81Br ion. For all ion images: field of view
 23.4 m2 to 28.9 28.9 m2, 512 shots/pixel,
scale bars, with amplitude in number of counts,
mplitude of the color scale corresponds to the
ion image, and could be read as [0, mc]; tc is theed a
ning
eas o
s; (g)
as f
e 23.4
olor
he a
each(sum of counts in all the pixels).
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lipid cytoplasmic droplets are present in corpora lutea
only at the day of diestrus [48]. In the conditions
suitable to enable TOF-SIMS imaging, the produced
sections enabled a satisfactory histologic analysis, but
did not allow to fully characterizing the histologic stage
of corpora lutea. Like other organo–halogen com-
pounds, including polybrominated biphenyls (PBB)
and PCBs, PBDE are relatively lipid soluble xenobiotics.
Compounds like PCB have been shown to adversely
affect progesterone production [49]. It could therefore
be hypothesized that DBDE (or its metabolites) present
at the level of the corpora lutea may disrupt natural
steroidogenesis in the ovary.
In these experiments, the maximum spatial resolu-
tion provided by TOF-SIMSmass spectrometry imaging
was not fully implemented. Moreover, the primary ion
dose of a few 1010 ions per cm2 used to record the ion
images shown in Figure 5 was several orders of mag-
nitude below the so-called static SIMS limit. A second
image was therefore recorded for specific areas of the
same ovarian section. This is shown in Figure 6, where
the 81Br ion, which appeared to accumulate in Figure
5d, was mapped with a better spatial resolution and
higher primary ion fluence. Figure 6a shows the optical
image after Masson’s trichrome staining from the dosed
rat ovary section in which the red color square delimi-
tates the analyzed area. Figure 6b shows the 81Br ion
image, and Figure 6c the same image after a reduction
of the number of pixels from 256 256 to 128 128, the
intensity of each pixel now corresponding to the sum of
four adjacent pixels. This method allowed in the present
case to improve the apparent contrast of images, at the
expense of a reduction of the spatial resolution by a
Figure 6. Precise localization of 81Br in rat ov
of an ovary section of dosed rat. The red squ
recorded. (b) TOF-SIMS negative ion images of t
an adrenal of dosed rat. (c) Same image as (b), b
four adjacent pixels. Field of view 2.7  2.7 mm2
128 128 pixels, pixel size 21 21 m2 (c), 512 s
bars, with amplitude in number of counts, are in
of the color scale corresponds to the maximum
is the total number of counts recorded for the specififactor of 2. This additional magnified acquisition clearly
confirmed the localization of the bromide ion in the
corpus luteum.
Conclusion
TOF-SIMS imaging using a bismuth cluster ions
source allowed for the first time and with a high
precision to localize the residues of a xenobiotic of
large toxicological interest, namely the brominated
flame retardant DBDE, at the level of its target
tissues. DBDE was spotted in well-defined parts of
two endocrine glands, as demonstrated by in vivo
experiments carried out in rat as a model animal.
Although DBDE was not detected in its molecular
form, it was possible to map it at the surface of
adrenal glands and ovaries thanks to the detection of
the 81Br isotope of the bromide ion, which was only
detected in organs from dosed rats. This ion was
located in the cortical area of adrenal glands. Despite
the low amount of work documenting BFR’s effects,
this appears to be consistent with the several studies
that previously demonstrated a link between PCB
exposure and cortical hyperplasia (as well as related
immunotoxic effects). Indeed, these organo–halogen
compounds are very close to DBDE in terms of
chemical structure. In ovaries from dosed rat, the
81Br ion was detected in active corpora lutea, which
is even more alarming than the previously released
data demonstrating that, quantitatively, ovaries are
the second main target tissue of DBDE in rat [21].
Given the fact that some PBDE metabolites have been
shown to act as nuclear receptor ligands [10], TOF-
(a) Optical image of trichrome Masson staining
dicates the area in which the ion image was
r ion recorded at the surface of a section from
ter having summed the number of counts of all
 256 pixels, pixel size 10.5  10.5 m2 (b) and
pixel, fluence 1.4 1011 ions · cm2. Color scale
ed to the right of each ion image. The amplitude
er of counts mc and could be read as [0, mc]; tcary.
are in
he 81B
ut af
, 256
hots/
dicat
numbed m/z (sum of counts in all the pixels).
1844 SEYER ET AL. J Am Soc Mass Spectrom 2010, 21, 1836–1845SIMS imaging techniques could provide valuable
data, enabling to better understand the possible en-
docrine disrupting effects of DBDE, as well as lower
brominated PBDE.
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